Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Stephen J. Kanes, MD, PhD
Sage Therapeutics, Inc, Cambridge, Massachusetts
JCP
Original Research
Effect of Zuranolone vs Placebo in MDD
February 20, 2023
This phase 3 RCT found significant improvement in depressive symptoms with zuranolone beginning at day 3 of treatment.
Anita H. Clayton
,
Robert Lasser
,
Indrani Nandy
, et al
JCP
Original Research
Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression
January 30, 2023
Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived functional health in patients with PPD.
Kristina M. Deligiannidis
,
Leslie Citrome
,
Ming-Yi Huang
, et al